An accomplished pharmaceutical industry executive, John Klein serves as the chairman of Cambridge Therapeutics in Alpine, NJ. In addition to directing the business development of Cambridge Therapeutics, John Klein recently founded a new venture in the emerging field of enterprise performance management (EPM).
Based in Alpine, NJ, the newest company is called Bilogix. A provider of strategic consulting services to a range of companies and organizations, Bilogix draws on the business-development and technological expertise of its team to help enterprises enhance their information technology (IT) infrastructure and achieve maximum operational efficiency.
The highly complex field of EPM encompasses many aspects, such as visualization of business strategy and metrics using tools such as strategy maps and performance dashboards. In the area of budgeting, EPM authorities use a range of resources to support financial analysis and decision-making, including cost and profitability modeling tools and improved management reporting systems. Another overarching EPM-solution approach is the integrated performance management system, which gives executives the feedback they need to evolve as productive and effective professionals.